Certificate of Analysis
Third Party Tested
Molecular Profile
Compound
Oxytocin
Batch #
20260605
Formula
C43H66N12O12S2
Mol Wt
1007.193 g/mol
CAS
50-56-6
Latest
ISO 17025
8× Testing
99.4%
Purity
VariantOxytocin
COA ##13796
Labeled10mg
Validation KeyAXISBIOTECH
Tested08/25/26
Full QC Panel - 8× tested
✓
Purity (HPLC) - 99.4%
✓
Net Peptide Content - 10mg
✓
Identity (HPLC) - Oxytocin
✓
Fentanyl Screen - Not Detected
✓
HPLC Conformity mean - >99%
✓
ISO/IEC 17025 Accredited
Storage Requirements
Stability Information
Lyophilized (powder)
−20°C long-term
2–8°C
Reconstituted
Recommended condition
Light protection
Store away from light
Sealed lyophilized vials are heat-stable; refrigerating or freezing sealed vials is optional. 2–8°C applies to reconstituted solutions.
Peer-Reviewed Literature
Research & References
Research and reference material related to this compound.
01
Intranasal oxytocin: highlighting the limitations of translating animal studies to humans
02
Oxytocin as a target for the pharmacotherapy of mental health disorders
03
Oxytocin as a potential therapeutic agent for brain disorders
04
Oxytocin and cardiovascular health: recent advances and future perspectives
05
Oromucosal administration of oxytocin using medicated lollipops alters social attention, similar to intranasal and lingual routes
Safety & Regulatory Compliance Warning
These products are intended solely for laboratory research and analytical applications. They have not been evaluated by the U.S. Food and Drug Administration (FDA) and are not approved for therapeutic use, diagnosis, treatment, or prevention of disease. Under no circumstances should these materials be used for human or animal consumption.
